Aims and Scope
Journal of Bioequivalence & Bioavailability is a bimonthly journal dedicated to publishing high-quality papers that describe the most significant and cutting-edge research in all areas of Bioequivalence and Bioavailability. As well as reflecting the traditional core subjects of Generic drug, BA/BE studies, etc, the journal also features a broad range of research including, but not limited to, Biosimilars, Biowaivers, Clinical pharmacy, Toxicology, Bioaccessibility, Absolute bioavailability, etc.
In addition to primary research, Journal of Bioequivalence & Bioavailability also publishes review articles, news and views, research highlights, commentaries, opinions about important work reported in other journals, commentaries, book reviews, correspondence, and analysis of the broader picture beyond the laboratory. In this way, the journal aims to be the voice of the worldwide Bioequivalence and Bioavailability scientific community.
Journal of Bioequivalence & Bioavailability is committed to publishing original research in all areas through a fair and rigorous peer-review process. It offers authors high visibility for their papers, access to a broad readership, high standards of copy editing and production, rapid publication and independence from scientific societies and others.
Categories of papers considered includes:
- Advances in Bioavailability.
- Anvisa Bioequivalence
- BA/BE Studies
- Bioequivalence Anticancers
- Bioequivalence Antidiabetics
- Bioequivalence Antidiuretics
- Bioequivalence Antipsychotics
- Drug Purity and Stability Studies
- Biopharmaceutics & Drug Disposition
- Bioavailability of Dietary supplements
Longdom Publishing SL is ardent to Open Access. We strongly believe that removing barriers to research published online will greatly aid to the progress in Longdom scientific and technical disciplines.
All published articles will be assigned DOI provided by CrossRef. Journal of Bioequivalence & Bioavailability will keep upto date with latest advances in the field and papers published in Journal of Bioequivalence & Bioavailability will reach the readers directly by email for free of cost.
Distributed widely through the Internet.
Archived online in the transactions of the Longdom Publishing SL, which provides the international scientific community with immediate and permanent access to individual papers.
Journal of Bioequivalence & Bioavailability accepts online letters to the editors, brief comments that contributes to the previously published articles or other relevant findings in Longdom field.
Open Access is a publication model, that enables the dissemination of research articles to the global community without restriction usually through the internet. Thus, all articles published under Open Access can be accessed by anyone with internet connection. Journal of Bioequivalence & Bioavailability strongly supports the Open Access initiative. Abstracts and full texts (HTML, PDF and XML format) of all articles published by Journal of Bioequivalence & Bioavailability are freely accessible to everyone immediately after publication.
All works published by Longdom Publishing SL are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. Journal of Bioequivalence & Bioavailability supports the Bethesda Statement on Open Access Publishing.
Definition of Open Access Publication
An Open Access Publication is one that meets the following two conditions:
- The author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
- A complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable Open Access, unrestricted distribution, interoperability, and long-term archiving (for the biomedical sciences, PubMed Central is such a repository).
a member of Publisher International linking Association, PILA, Journal of Bioequivalence & Bioavailability (of Longdom Publishing SL) follows the Creative Commons Attribution License and Scholars Open Access publishing policies.
Community standards, rather than copyright law, will continue to provide the mechanism for enforcement of proper attribution and responsible use of the published work, as they do now.